0000885590-13-000002.txt : 20130103 0000885590-13-000002.hdr.sgml : 20130103 20130103162110 ACCESSION NUMBER: 0000885590-13-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121231 FILED AS OF DATE: 20130103 DATE AS OF CHANGE: 20130103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MELAS KYRIAZI THEO CENTRAL INDEX KEY: 0001216078 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 13506993 MAIL ADDRESS: STREET 1: 4787 LEVY STREET CITY: MONTREAL STATE: A8 ZIP: H4R 2P9 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4787 LEVY STREET STREET 2: MONTREAL CITY: QUEBEC STATE: A8 ZIP: H4R 2P9 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 4787 LEVY STREET STREET 2: MONTREAL CITY: QUEBEC STATE: A8 ZIP: H4R 2P9 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2012-12-31 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001216078 MELAS KYRIAZI THEO 4787 LEVY STREET MONTREAL A8 H4R 2P9 QUEBEC, CANADA 1 0 0 0 Common Stock, no par value 2012-12-31 4 A 0 428 0 A 216379 D Quarterly grant of Restricted Share Units. This number represents common shares purchased and other equity awards that were previously reported in Table 1. by: Nicholas Zanoni for Theo Melas-Kyriazi 2013-01-03